Kinetics of micronucleus formation in relation to chromosomal aberrations in mouse bone marrow.
A simulation analysis of the kinetics of micronucleus formation in polychromatic erythrocytes in mouse bone marrow was performed after a single administration of 3 chemicals--mitomycin C (MMC), 6-mercaptopurine (6-MP) and 1-beta-D-arabinofuranosylcytosine (Ara-C)--with different modes of action. The time-response patterns in the incidence of chromosomal aberrations and micronuclei after treatment with each chemical were compared and subjected to the simulation study with 3 parameters. Two of them, the time between the final mitotic metaphase of the erythroid series and nucleus expulsion (T1), and the duration of the polychromatic erythrocyte (PCE) stage in the bone marrow (T2), were almost identical for the 3 chemicals. However, the coefficients of formation rate of micronucleated cells resulting from cells with chromosomal aberration(s) (k) differed: Ara-C differed from the other two. These results indicate that chromosomal aberrations, especially chromatid breaks and probably gaps, induced by this chemical, effectively contribute to micronucleus formation. The DNA content of micronuclei was also compared to the length of acentric fragments induced by Ara-C and it was found that their distributions were comparable. These findings strongly suggest that chromosomal aberrations induced by chemicals are essential events for the induction of micronuclei in the PCE of bone marrow.
D000818:Animals; D001853:Bone Marrow / Q000187:drug effects*; D002467:Cell Nucleus / Q000187:drug effects* / Q000648:ultrastructure; D002869:Chromosome Aberrations; D003561:Cytarabine / Q000633:toxicity; D004913:Erythrocytes, Abnormal / Q000648:ultrastructure; D008297:Male; D015122:Mercaptopurine / Q000633:toxicity; D051379:Mice; D016685:Mitomycin; D008937:Mitomycins / Q000633:toxicity; D008938:Mitosis / Q000187:drug effects; D009152:Mutagenicity Tests; D013997:Time Factors
D008937:Mitomycins; D003561:Cytarabine; D016685:Mitomycin; D015122:Mercaptopurine